Terminalia glabrescens
Terminalia glabrescens · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Terminalia glabrescens is a significant botanical species known for its unique biological properties. This plant is particularly noted for its rich concentration of bioactive polyphenols. Researchers often utilize various extracts from its tissues to study these potent chemical compounds. These specialized preparations serve as a foundation for exploring the plant's diverse therapeutic potential. Understanding its chemical profile is essential for advancing natural product research.
- Synonyms
- Myrobalanus Cambessedesii · Myrobalanus Glabrescens · 1 more
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Common Names
Terminalia glabrescens is a versatile plant known by a diverse array of local names across different regions. It is frequently referred to as Amarelinho or Amêndoa-brava, reflecting its unique physical characteristics. In certain areas, people also call it Canoé-de-botão to distinguish it from other similar species. The plant is further recognized by the traditional names Capitão and Capitão-do-campo. These various common names highlight the deep cultural and linguistic connection people have with this specific species.
Sources: Catalogue of Life (COL)
Synonyms
Terminalia glabrescens is a botanical species that has been documented under several different scientific names throughout history. Due to various taxonomic classifications, it is recognized by the synonym Chuncoa brasiliensis in certain academic contexts. It is also frequently referred to as Myrobalanus cambessedesii within botanical literature. Furthermore, the plant is identified by the synonym Myrobalanus glabrescens, illustrating the complexity of its nomenclature. Understanding these overlapping names is essential for researchers tracking the evolutionary lineage of the species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Terminalia glabrescens is a notable botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further resides in the order Myrtales, showcasing its specific evolutionary lineage. The plant is a distinguished member of the genus Terminalia, which highlights its structural characteristics. Finally, it is nested within the family Combretaceae, completing its formal biological identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia glabrescens is a species widely distributed throughout the diverse landscapes of South America. Within this region, it maintains a significant presence across the vast expanse of Brazil. The plant can be found thriving in various territories, including the northern and northeastern parts of the country. Its range also extends southward and southeastward, covering a broad geographic area. Furthermore, the species is established within Brazil's west-central regions, demonstrating remarkable adaptability to different environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia glabrescens is a self-supporting tree that establishes a sturdy presence within its natural habitat. This species typically exhibits a growth form characterized by a distinct tree structure. Depending on environmental conditions, it reaches a maximum height of approximately 12 meters. In some instances, however, the plant can extend its stature to a maximum height of 15 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Terminalia glabrescens demonstrates significant potential in managing inflammation by targeting key chemical mediators. The plant extract effectively inhibits the production of TNF-α in a concentration-dependent manner. Additionally, it provides significant inhibition of CCL2 release in stimulated human monocytic leukemia cells. These anti-inflammatory effects are further enhanced through the fractionation of the extract into specific active components. By blocking both TNF-α and CCL2, Terminalia glabrescens serves as a promising candidate for treating chronic inflammatory diseases.
Preparations
Terminalia glabrescens is prepared as extracts to evaluate its biological effects on inflammatory mediators. These specific extracts were tested for their ability to inhibit the production of TNF-α and CCL2 in THP-1 cells. Research indicates that the Terminalia glabrescens extracts demonstrate a concentration-dependent inhibition of TNF-α. Furthermore, the preparation of these extracts allowed for fractionation, revealing that low polar fractions elicited significant CCL2 inhibition. Such preparation and testing suggest that the components within these extracts could be developed for treating chronic inflammatory diseases.